It's obvious . Converting options . It's still a 90% gain for the holders . There is some good selling in this still.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025